The Ubiquitin and Ub-like Proteins Conference: Cell Functions and Therapeutic Targeting
July 24–29, 2022
July 24-29, 2022
The cross-fertilization of ideas and approaches that the meeting engenders cannot be underestimated. It convenes world-renowned experts and beginning investigators who represent a variety of disciplines and approaches within the large ﬁeld of protein modiﬁcation by UB and UBLs.
By assembling such a broad group in an intimate setting, the conference helps bridge the gaps between the various subspecialties and moves toward a comprehensive and current understanding of the molecular and genetic basis of the UB family pathways.
The conference brings together academics from the U.S. and Europe and trainees and independent investigators from the biotech industry who have an interest in the ubiquitin system.
Have questions about the conference? Email us at email@example.com.
In particular, it facilitates cross talk and collaboration between investigators who: 1) Examine biological roles of speciﬁc UB/UBL modiﬁcation pathways; 2) Deﬁne networks regulating and regulated by UB/UBL conjugation; 3) Study structures and mechanisms of action of enzymes mediating UB/UBL modiﬁcations and machineries that recognize these modiﬁcations and translate them into altered and/or targeted protein functions; 4) Develop small molecules that target UB/UBL modiﬁcation cascades as probes or potential therapeutics.
Conference sessions will present the latest research and foster discussion on:
- Mechanism of Ubiquitin Conjugation & Deconjugation
- Ubiquitin-like Proteins and Atypical Ubiquitin
- The Role of Ubiquitin in Diverse Diseases
- Therapeutic Targeting and Tools
- Signaling Pathways and Cell Fate
- Organelles and Pathways
- Protein Quality Control and Stress
View the preliminary agenda.
Michele Pagano, MD
Kylie Walters, PhD
Claudio Joazeiro, PhD
The poster setup and removal schedule will be posted soon. The poster board is 7’10” wide by 4’ high and the poster board surface area is 91 inches wide by 44.75 inches tall. Your poster should not exceed the poster board surface. Push pins will be provided for poster presenters.
Invited Speakers: $1199
Invited Speakers: $1199
The registration fee does not include lodging. Please book your lodging through either option below:
Online or by phone at 1-508-765-8000 (Mention “2022 FASEB Conference” for the discounted rate).
Be in the center of activity: Enjoy quick and easy access to all conference functions and networking opportunities.
Additional protection: FASEB may be able to assist you with any issues that arise with the hotel.
The airport provides information on ground transportation options here for BOS and here for BDL. The average cost of a taxi from this airport to the conference location is approx. $180 for BOS and $160 for DBL.
To request a rideshare with other participants click here. Please note that participation is completely voluntary and the responsibility of the individual. FASEB will not be matching or assigning rides and is not responsible for any liability or financial obligation that may arise from voluntary matching made using rideshare options.
Knight’s Limo is providing a 10% discount on shared van shuttle services between the Logan International Airport and the Southbridge Conference Center for FASEB attendees. With the 10% discount, the shuttle service for each person one way would be $103. To book online click here and enter “FASEB” in the Group/ID/Discount Code and click on “Login”. If you call the office to book, please refer to either FASEB or the profile ID #272119.
SuperShuttle is offering 5% off airport rides to FASEB attendees. To make a reservation, click here.
Thanks to generous support of our donors, we have several meeting scholarships. Up to $500 will be available to trainees who are presenting a talk and/or poster at the meeting. Awards will be used to reimburse attendee registration/travel. Trainees from under-represented groups and/or with financial need are particularly encouraged to apply. Click here to learn more.
Funding for this conference was made possible (in part) by 1R13CA271471-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.